Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo Inhibition of BCRP/ABCG2 Mediated Transport of Nitrofurantoin by the Isoflavones Genistein and Daidzein: A Comparative Study in Bcrp1 ^−/− Mice

By Merino Gracia   Perez Miriam   Real Rebeca   Egido Estefania   Prieto Julio   Alvarez Ana  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2098-2105

Springer Publishing Company

Access to resources Recommend Favorite

Functional Analysis of SNPs Variants of BCRP/ABCG2

By Kondo Chihiro   Suzuki Hiroshi   Itoda Masaya   Ozawa Shogo   Sawada Jun-ichi   Kobayashi Daisuke   Ieiri Ichiro   Mine Kazunori   Ohtsubo Kenji   Sugiyama Yuichi  

Pharmaceutical Research, Vol. 21, Iss. 10, 2004-10 ,pp. : 1895-1903

Springer Publishing Company

Access to resources Recommend Favorite

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

By  

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

By Hu Miao   To Kenneth KW   Mak Valiant WL   Tomlinson Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 49-62

Informa Healthcare

Access to resources Recommend Favorite